In particular, it has been observed that in breast cancer, E-cadherin physically interacts with p62/SQSTM1 to mediate LC3 targeting and consequent delivery to LC3-containing autophagosomes (Damiano et al., 2020; Santarosa and Maestro, 2021). Here, MAP1LC3A is linked to breast cancer.